Applied Clinical Trials
November 01, 2009
Issue PDF
0
0
GLOBAL TRIALS : South Africa?s Positioning Fosters Healthy Trial Landscape Croatia?s Dynamic Qualities CROs Must Manage Italy?s Regulatory Makeover EDC?s Evolution in Japan Also in this issue : Postmarketing Pushes Back Approvals, EU Regulators Increase Involvement, Site Shake-Out Benefits Those That Remain, Is in Silico Modeling the Economic Solution?
November 01, 2009
Community
0
0
Industry news focusing on the people and organizations who work in the clinical trials profession
November 01, 2009
Feature Article
0
0
As a part of Europe, but not the European Union, trials in Croatia can encounter special challenges
November 01, 2009
News
0
0
Implementing postmarketing strategies early on to avoid on-the-spot and costly requirements upon submission.
November 01, 2009
Feature Article
0
0
While it has yet to be fully integrated, electronic data capture is gaining ground in Japan.
November 01, 2009
A Closing Thought
0
0
Changing current business models with the use of new advancements for more sustainability.
November 01, 2009
Clinical Trials Insights
0
0
Economic factors and sponsor practices will dramatically alter the investigative site landscape.
November 01, 2009
News
0
0
A rising initiative in Wales led by the International Business of Wales (IBW) promotes company growth in the region.
November 01, 2009
Feature Article
0
0
Economical development and regulatory standards make the country a logical choice for trials.
November 01, 2009
View from Brussels
0
0
Health concerns require EU regulators to become more involved in the politics of health care.
November 01, 2009
View from Washington
0
0
FDA reviewers strive to assess new postmarketing programs while also evaluating applications.
November 01, 2009
Feature Article
0
0
How Italy's new quality-driven regulations will ask more of CROs conducting activities in the country.
November 01, 2009
Global News
0
0
A major European congress looks set to focus attention on the growing campaign for more participation of the elderly in clinical trials.